Lumida
/ARGX
⌘K
argenx SE

argenx SE

ARGX
$860.55USD+0.30%+2.58 today

MARKET CAP

39.2B

P/E (TTM)

38.3x

FWD P/E

27.9x

DAY RANGE

$844 – $863

52W RANGE

$561
$954

AI Summary

Stalk
TrimMedium

The stock is entrenched in a Stage 4 decline with a clear lower-high/lower-low sequence and price below key EMAs, reinforcing medium-term bearish control. With long-term uptrend intact but short side as the only tradable bias, we defer execution until a bounce into the declining short-term EMAs or 50-day MA for trimming exposure. Current price behavior remains neutral for timing, awaiting resistance rejection before acting.

  • Q1 2026 net product sales hit $1.3B (+63% YoY), driven by VivGuard uptake
  • Strong cash position of $4.9B provides flexibility for R&D and trial funding
  • Elevated leverage risk could constrain capacity in adverse economic conditions
Full analysis →
Insider Trades0 trades
No trades match the current filters